Johnson & Johnson (JNJ) Sector
Health Care

(Current) $144.47
1.42 (0.99%) Open Price: 144.47

 

Johnson & Johnson is a multinational corporation that was founded in 1886 by Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson. The company is headquartered in New Brunswick, New Jersey, United States. Johnson & Johnson is one of the largest healthcare companies in the world, focusing on three main sectors: pharmaceuticals, medical devices, and consumer health.

 

In the pharmaceutical sector, Johnson & Johnson develops and manufactures a wide range of prescription drugs and biologics. The company's pharmaceutical portfolio includes products for various therapeutic areas such as oncology, immunology, cardiovascular diseases, infectious diseases, and neurological disorders. Johnson & Johnson's pharmaceutical division is known for its innovative research and development efforts to bring new treatments and therapies to patients.

 

The medical devices segment of Johnson & Johnson produces a diverse range of medical devices, equipment, and diagnostic tools. These products are used in hospitals, clinics, and other healthcare settings to diagnose, monitor, and treat patients. The company's medical devices portfolio includes surgical instruments, orthopedic implants, vision care products, diabetes care devices, and advanced diagnostic equipment.

 

Johnson & Johnson's consumer health division manufactures and markets a wide array of over-the-counter consumer products. These products include skincare and beauty products, baby care items, oral care products, women's health products, and over-the-counter medications. The consumer health segment caters to the everyday healthcare needs of consumers worldwide, offering trusted brands like Johnson's, Neutrogena, Tylenol, and Band-Aid.

 

Johnson & Johnson went public in 1944 and has been listed on the New York Stock Exchange (NYSE) under the ticker symbol "JNJ" since then. As a public company, Johnson & Johnson has a long-standing track record of financial stability and growth. It is widely recognized for its commitment to quality, innovation, and ethical business practices in the healthcare industry.

 

Over the years, Johnson & Johnson has established itself as a leader in the healthcare sector, with a strong global presence. The company's core values include a dedication to improving human health and well-being through its products and services. Johnson & Johnson continues to invest in research and development, strategic partnerships, and acquisitions to advance medical science and enhance patient care.

 



 

(12/20/24) $144.47
(12/21/24) $143.05
(12/21/24) (Qty.)13,246,892
(12/20/24) $142.75
(12/20/24) $145.47
(12/15/24) $142.75
(12/01/24) $155.00
Stocktwits
LetsEncrypt SSL Secure Stripe Payment Processing